hotspot -WSS

hotspot

author：leisure time 2025-09-30 06:09:33 - browse：92723

Perrigo Opill press photo – pharma coverage from STAT — Opill, the first over-the-counter birth control pill, is on its way to U.S. stores. Perrigo via AP

WASHINGTON — The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin.

Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company’s suggested retail price. It will also be sold online.

The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription. Ireland-based Perrigo noted there will be no age restrictions on sales, similar to other over-the-counter medications.

Opill is an older class of contraceptive, sometimes called minipills, that contain a single synthetic hormone, progestin, and generally carry fewer side effects than more popular combination estrogen and progestin pills.

Newsletters

Sign up for Morning Rounds

Understand how science, health policy, and medicine shape the world every day

Please enter a valid email address. Privacy Policy

The launch gives U.S. women another birth control option amid the legal and political battles over reproductive health, including the reversal of Roe v. Wade, which has upended abortion access across the U.S. Opill’s approval is unrelated to the ongoing court battles over the abortion pill mifepristone. And anti-abortion groups have generally emphasized that they do not oppose contraceptives to prevent pregnancies.

Birth control pills are available without a prescription across much of South America, Asia, and Africa.

The drug’s approval came despite some concerns by FDA scientists about the company’s results, including whether women with certain medical conditions would understand that they shouldn’t take the drug.

Dr. Verda Hicks, president of the American College of Obstetricians and Gynecologists, in a statement, said studies have shown that patients, including adolescents, can effectively screen themselves to use the pills.

— Matthew Perrone

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Devoted Health’s losses in Medicare Advantage persist

WSS

Bernie brings in new pharma CEOs to talk drug prices

Cano Health’s bankruptcy is a warning for Medicare Advantage

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Morphosys mixed study results for blood cancer drug

Medicare Advantage plans can’t deny care with AI, CMS warns

Does good food count as health care? Study aims to find out

focus

hotspot

Sign up for Morning Rounds

explore

In Memoriam: Notable people who died in 2023

Adopting new red light myopia treatments may be short

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Drug repurposing or repositioning? The language matters

Cano Health’s bankruptcy is a warning for Medicare Advantage

Jerome Adams on the need for new antivirals for Covid

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Tori Bowie and the unacceptable rates of Black maternal death

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

leisure time

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Updated Covid vaccine has 54% effectiveness, new study suggests

Wegovy, Zepbound and weight loss drugs that preserve muscle

Bernie brings in new pharma CEOs to talk drug prices

Cano Health’s bankruptcy is a warning for Medicare Advantage

Surge of respiratory disease in China has likely explanation

leisure time

focus

leisure time

hotspot